Mitotech S.A, a clinical-stage biotechnology company, is proud to announce that its COO, Anton Petrov, is invited to present at Bio Investor Forum 2023. The event will take place on October 17-18, 2023 in San Francisco, U.S. Hope to see you at Bio Investor Forum. “We look forward to our presentation in San Francisco and to the opportunity to present our company to potential investors. We have exciting new efficacy data generated by Obesity and NASH models that Dr. Petrov will share during the event,” said Natalia Perekhvatova, the CEO of Mitotech.
About Mitotech S.A.
Mitotech S.A. is a Luxembourg-based late clinical stage biotechnology company developing drugs to treat the mitochondrial oxidative stress underlying metabolic and neurodegenerative disorders. Mitotech’s products are based on novel small molecules that inhibit ferroptosis within mitochondria.